speb/financial-data huggingface dataset:
PHA.V cash_flow (annual, 2025-09-30) — Stock Based Compensation: -114000.00
PHA.V cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: -13000.00
PHA.V balance_sheet (annual, 2025-09-30) — Stockholders Equity: -11273000.00
PHA.V balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -11273000.00
PHA.V balance_sheet (annual, 2025-09-30) — Tangible Book Value: -36154000.00
PHA.V balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -36154000.00
PHA.V income_statement (annual, 2025-09-30) — Tax Effect Of Unusual Items: -381045.66
PHA.V income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -257689.19
PHA.V income_statement (annual, 2025-09-30) — Tax Provision: -1971000.00
PHA.V income_statement (quarterly, 2025-09-30) — Tax Provision: -517000.00
PHA.V income_statement (annual, 2025-09-30) — Tax Rate For Calcs: 0.11
PHA.V income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.07
PHA.V balance_sheet (annual, 2025-09-30) — Taxes Receivable: 593000.00
PHA.V balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 593000.00
PHA.V cash_flow (annual, 2025-09-30) — Taxes Refund Paid: -140000.00
PHA.V balance_sheet (annual, 2025-09-30) — Total Assets: 47219000.00
PHA.V balance_sheet (quarterly, 2025-09-30) — Total Assets: 47219000.00
PHA.V balance_sheet (annual, 2025-09-30) — Total Capitalization: -11273000.00
PHA.V balance_sheet (quarterly, 2025-09-30) — Total Capitalization: -11273000.00
PHA.V balance_sheet (annual, 2025-09-30) — Total Debt: 44369000.00
PHA.V balance_sheet (quarterly, 2025-09-30) — Total Debt: 44369000.00
PHA.V balance_sheet (annual, 2025-09-30) — Total Equity Gross Minority Interest: -11273000.00
PHA.V balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -11273000.00
PHA.V income_statement (annual, 2025-09-30) — Total Expenses: 110567000.00
PHA.V income_statement (quarterly, 2025-09-30) — Total Expenses: 22979000.00
PHA.V balance_sheet (annual, 2025-09-30) — Total Liabilities Net Minority Interest: 58492000.00
PHA.V balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 58492000.00
PHA.V balance_sheet (annual, 2025-09-30) — Total Non Current Assets: 26325000.00
PHA.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 26325000.00
PHA.V balance_sheet (annual, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 6191000.00
PHA.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 6191000.00
PHA.V income_statement (annual, 2025-09-30) — Total Operating Income As Reported: -9733000.00
PHA.V income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -3103000.00
PHA.V income_statement (annual, 2025-09-30) — Total Other Finance Cost: 145000.00
PHA.V income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 0.00
PHA.V balance_sheet (annual, 2025-09-30) — Total Tax Payable: 1088000.00
PHA.V balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 1088000.00
PHA.V income_statement (annual, 2025-09-30) — Total Unusual Items: -3366000.00
PHA.V income_statement (quarterly, 2025-09-30) — Total Unusual Items: -3496000.00
PHA.V income_statement (annual, 2025-09-30) — Total Unusual Items Excluding Goodwill: -3366000.00
PHA.V income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -3496000.00
PHA.V balance_sheet (annual, 2025-09-30) — Tradeand Other Payables Non Current: 56000.00
PHA.V balance_sheet (quarterly, 2025-09-30) — Tradeand Other Payables Non Current: 56000.00
PHA.V balance_sheet (annual, 2025-09-30) — Working Capital: -31407000.00
PHA.V balance_sheet (quarterly, 2025-09-30) — Working Capital: -31407000.00
PHA.V income_statement (annual, 2025-09-30) — Write Off: 301000.00
PHA.V income_statement (quarterly, 2025-12-31) — +Operating Expense: 4283000.00
PHA.V income_statement (quarterly, 2025-12-31) — +Total Revenue: 17835000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 2581000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 14500000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1010000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 1145000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 1145000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 1267000.00
PHA.V income_statement (quarterly, 2025-12-31) — Basic Average Shares: 55514151.00
PHA.V income_statement (quarterly, 2025-12-31) — Basic EPS: -0.05
PHA.V cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 1396000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -411000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 1073000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Capital Stock: 14314000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 92000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 92000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -1309000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -128000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 133000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Change In Payable: -1814000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -1814000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 42000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Change In Receivables: 2063000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 291000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Changes In Cash: -1304000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Common Stock: 14314000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -13799000.00
PHA.V income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 15109000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 3336000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Current Assets: 17286000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 142000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Current Debt: 43333000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 43475000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 50605000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -208000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Deferred Tax: -208000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Depreciation: 119000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 1264000.00
PHA.V income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 1264000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 1264000.00
PHA.V income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 1264000.00
PHA.V income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 55514151.00
PHA.V income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.05
PHA.V income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -2549000.00
PHA.V income_statement (quarterly, 2025-12-31) — EBIT: -1522000.00
PHA.V income_statement (quarterly, 2025-12-31) — EBITDA: -258000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 48000.00
PHA.V cash_flow (quarterly, 2025-12-31) — End Cash Position: 92000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -1309000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -278000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: -191000.00
PHA.V income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: 191000.00
PHA.V income_statement (quarterly, 2025-12-31) — General And Administrative Expense: -27000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Goodwill: 10405000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 24113000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Gross PPE: 1233000.00
PHA.V income_statement (quarterly, 2025-12-31) — Gross Profit: 2726000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 565000.00
PHA.V income_statement (quarterly, 2025-12-31) — Interest Expense: 1235000.00
PHA.V income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 1235000.00
PHA.V income_statement (quarterly, 2025-12-31) — Interest Income: 7000.00
PHA.V income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 7000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Interest Received Cfi: 7000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Invested Capital: 29534000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -128000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 350000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Line Of Credit: 43333000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 931000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 931000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 350000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -650000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Net Debt: 43241000.00
PHA.V income_statement (quarterly, 2025-12-31) — Net Income: -2549000.00
PHA.V income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -2549000.00
PHA.V income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -2549000.00
PHA.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -2549000.00
PHA.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -2549000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -2549000.00
PHA.V income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -2549000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -378000.00
PHA.V income_statement (quarterly, 2025-12-31) — Net Interest Income: -1245000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -300000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -300000.00
PHA.V income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -1245000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -1009000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Net PPE: 1233000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 243000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -37912000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 2710000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 2710000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 48000.00
PHA.V income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -303000.00
PHA.V income_statement (quarterly, 2025-12-31) — Normalized Income: -2590605.01
PHA.V cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 133000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -191000.00
PHA.V income_statement (quarterly, 2025-12-31) — Operating Income: -1557000.00
PHA.V income_statement (quarterly, 2025-12-31) — Operating Revenue: 17835000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 55514151.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 340000.00
PHA.V income_statement (quarterly, 2025-12-31) — Other Income Expense: 45000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 13708000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 1264000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 2097000.00
PHA.V income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 3046000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Other Properties: 1233000.00
PHA.V income_statement (quarterly, 2025-12-31) — Other Special Charges: 146000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Payables: 3346000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 6682000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 448000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 1034000.00
PHA.V income_statement (quarterly, 2025-12-31) — Pretax Income: -2757000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -378000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -33000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Receivables: 14893000.00
PHA.V income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 15109000.00
PHA.V income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1264000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -650000.00
PHA.V income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 0.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -29463000.00
PHA.V income_statement (quarterly, 2025-12-31) — Salaries And Wages: -27000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 276000.00
PHA.V income_statement (quarterly, 2025-12-31) — Selling General And Administration: -27000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Share Issued: 55514151.00
PHA.V income_statement (quarterly, 2025-12-31) — Special Income Charges: 45000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 34000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -13799000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -37912000.00
PHA.V income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 3394.99
PHA.V income_statement (quarterly, 2025-12-31) — Tax Provision: -208000.00
PHA.V income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.08
PHA.V balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 393000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid: 255000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Total Assets: 42632000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Total Capitalization: -13799000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Total Debt: 44406000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -13799000.00
PHA.V income_statement (quarterly, 2025-12-31) — Total Expenses: 19392000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 56431000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 25346000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 5826000.00
PHA.V income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -1584000.00
PHA.V income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 17000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 765000.00
PHA.V income_statement (quarterly, 2025-12-31) — Total Unusual Items: 45000.00
PHA.V income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 45000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 40000.00
PHA.V cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -27000.00
PHA.V balance_sheet (quarterly, 2025-12-31) — Working Capital: -33319000.00
PHAR balance_sheet (annual, 2021-12-31) — Available For Sale Securities: 1449000.00
PHAR cash_flow (annual, 2021-12-31) — Common Stock Issuance: 4718000.00
PHAR cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: 0.00
PHAR income_statement (annual, 2021-12-31) — Gain On Sale Of Business: 0.00
PHAR balance_sheet (annual, 2021-12-31) — Investments In Other Ventures Under Equity Method: 7201000.00
PHAR cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 4718000.00
PHAR balance_sheet (annual, 2021-12-31) — Land And Improvements: 31000.00
PHAR cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 4718000.00
PHAR cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -25000000.00
PHAR balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 165000.00
PHAR balance_sheet (annual, 2021-12-31) — Other Payable: 34000.00
PHAR cash_flow (annual, 2021-12-31) — Purchase Of Business: 0.00
PHAR income_statement (annual, 2021-12-31) — Restructuring And Mergern Acquisition: 0.00
PHAR cash_flow (annual, 2021-12-31) — Sale Of Business: 0.00
PHAR income_statement (annual, 2022-12-31) — +Operating Expense: 178200000.00
PHAR income_statement (annual, 2022-12-31) — +Total Revenue: 205622000.00
PHAR balance_sheet (annual, 2022-12-31) — Accounts Payable: 8753000.00
PHAR balance_sheet (annual, 2022-12-31) — Accounts Receivable: 20964000.00
PHAR balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -19989000.00
PHAR balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 462297000.00
PHAR income_statement (annual, 2022-12-31) — Amortization: 4257000.00
PHAR income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 4257000.00
PHAR balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 403000.00
PHAR income_statement (annual, 2022-12-31) — Basic Average Shares: 65114286.00
PHAR income_statement (annual, 2022-12-31) — Basic EPS: 0.21
PHAR cash_flow (annual, 2022-12-31) — Beginning Cash Position: 191924000.00
PHAR balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 32884000.00
PHAR cash_flow (annual, 2022-12-31) — Capital Expenditure: -1977000.00
PHAR cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -1376000.00
PHAR balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 33308000.00
PHAR balance_sheet (annual, 2022-12-31) — Capital Stock: 7509000.00
PHAR balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 207342000.00
PHAR balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 207342000.00
PHAR cash_flow (annual, 2022-12-31) — Cash Dividends Paid: 0.00
PHAR cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -4982000.00
PHAR cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 5323000.00
PHAR cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 22458000.00
PHAR cash_flow (annual, 2022-12-31) — Change In Inventory: -15016000.00
PHAR cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 273000.00
PHAR cash_flow (annual, 2022-12-31) — Change In Payable: 11992000.00
PHAR cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 11992000.00
PHAR cash_flow (annual, 2022-12-31) — Change In Receivables: 2364000.00
PHAR cash_flow (annual, 2022-12-31) — Change In Working Capital: -387000.00
PHAR cash_flow (annual, 2022-12-31) — Changes In Cash: 22799000.00
PHAR balance_sheet (annual, 2022-12-31) — Common Stock: 7509000.00
PHAR balance_sheet (annual, 2022-12-31) — Common Stock Equity: 204638000.00
PHAR cash_flow (annual, 2022-12-31) — Common Stock Issuance: 2281000.00
PHAR balance_sheet (annual, 2022-12-31) — Construction In Progress: 6000.00
PHAR income_statement (annual, 2022-12-31) — Cost Of Revenue: 17562000.00
PHAR balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 43613000.00
PHAR balance_sheet (annual, 2022-12-31) — Current Assets: 277500000.00
PHAR balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 3465000.00
PHAR balance_sheet (annual, 2022-12-31) — Current Debt: 1768000.00
PHAR balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 5233000.00
PHAR balance_sheet (annual, 2022-12-31) — Current Liabilities: 59698000.00
PHAR cash_flow (annual, 2022-12-31) — Depreciation: 13188000.00
PHAR cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 13188000.00
PHAR income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 7154000.00
PHAR cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 13188000.00
PHAR income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 7154000.00
PHAR income_statement (annual, 2022-12-31) — Depreciation Income Statement: 2897000.00
PHAR income_statement (annual, 2022-12-31) — Diluted Average Shares: 71968421.00
PHAR income_statement (annual, 2022-12-31) — Diluted EPS: 0.19
PHAR income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 13674000.00
PHAR income_statement (annual, 2022-12-31) — EBIT: 20345000.00
PHAR income_statement (annual, 2022-12-31) — EBITDA: 33533000.00
PHAR income_statement (annual, 2022-12-31) — Earnings From Equity Interest: -1083000.00
PHAR cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 1083000.00
PHAR cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -7381000.00
PHAR cash_flow (annual, 2022-12-31) — End Cash Position: 207342000.00
PHAR balance_sheet (annual, 2022-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 6827000.00
PHAR cash_flow (annual, 2022-12-31) — Financing Cash Flow: -4982000.00
PHAR balance_sheet (annual, 2022-12-31) — Finished Goods: 12460000.00
PHAR cash_flow (annual, 2022-12-31) — Free Cash Flow: 20481000.00
PHAR cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 1185000.00
PHAR cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: -12242000.00
PHAR cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 0.00
PHAR income_statement (annual, 2022-12-31) — Gain On Sale Of Business: 12242000.00
PHAR income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 0.00
PHAR income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 3215000.00
PHAR balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -8737000.00
PHAR income_statement (annual, 2022-12-31) — General And Administrative Expense: 62443000.00
PHAR balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 75121000.00
PHAR balance_sheet (annual, 2022-12-31) — Gross PPE: 59134000.00
PHAR income_statement (annual, 2022-12-31) — Gross Profit: 188060000.00
PHAR income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 4376000.00
PHAR income_statement (annual, 2022-12-31) — Interest Expense: 5358000.00
PHAR income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 5358000.00
PHAR income_statement (annual, 2022-12-31) — Interest Income: 85000.00
PHAR income_statement (annual, 2022-12-31) — Interest Income Non Operating: 85000.00
PHAR cash_flow (annual, 2022-12-31) — Interest Paid Cff: -3952000.00
PHAR cash_flow (annual, 2022-12-31) — Interest Received Cfo: 85000.00
PHAR balance_sheet (annual, 2022-12-31) — Inventory: 42326000.00
PHAR balance_sheet (annual, 2022-12-31) — Invested Capital: 338024000.00
PHAR cash_flow (annual, 2022-12-31) — Investing Cash Flow: 5323000.00
PHAR balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 7230000.00
PHAR balance_sheet (annual, 2022-12-31) — Investments And Advances: 9731000.00
PHAR balance_sheet (annual, 2022-12-31) — Investments In Other Ventures Under Equity Method: 2501000.00
PHAR cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 2281000.00
PHAR cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
PHAR balance_sheet (annual, 2022-12-31) — Land And Improvements: 0.00
PHAR balance_sheet (annual, 2022-12-31) — Leases: 5282000.00
PHAR balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 29843000.00
PHAR balance_sheet (annual, 2022-12-31) — Long Term Debt: 131618000.00
PHAR balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 161461000.00
PHAR cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
PHAR cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -3311000.00
PHAR balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 2501000.00
PHAR balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 16271000.00
PHAR cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 7300000.00
PHAR cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 2281000.00
PHAR income_statement (annual, 2022-12-31) — Net Income: 13674000.00
PHAR income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 13674000.00
PHAR income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 13674000.00
PHAR income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 13674000.00
PHAR income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 13674000.00
PHAR cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 14987000.00
PHAR income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 13674000.00
PHAR cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -601000.00
PHAR income_statement (annual, 2022-12-31) — Net Interest Income: -5378000.00
PHAR cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 0.00
PHAR cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -3311000.00
PHAR cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -3311000.00
PHAR income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -5378000.00
PHAR balance_sheet (annual, 2022-12-31) — Net PPE: 39145000.00
PHAR balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 129517000.00
PHAR balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 22973000.00
PHAR balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 22973000.00
PHAR balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 228000.00
PHAR income_statement (annual, 2022-12-31) — Normalized EBITDA: 22452000.00
PHAR income_statement (annual, 2022-12-31) — Normalized Income: 3563798.23
PHAR cash_flow (annual, 2022-12-31) — Operating Cash Flow: 22458000.00
PHAR cash_flow (annual, 2022-12-31) — Operating Gains Losses: -11159000.00
PHAR income_statement (annual, 2022-12-31) — Operating Income: 9860000.00
PHAR income_statement (annual, 2022-12-31) — Operating Revenue: 205622000.00
PHAR balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 656348225.00
PHAR balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 1768000.00
PHAR balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -8737000.00
PHAR income_statement (annual, 2022-12-31) — Other Gand A: 14717000.00
PHAR income_statement (annual, 2022-12-31) — Other Income Expense: 10505000.00
PHAR balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 75121000.00
PHAR cash_flow (annual, 2022-12-31) — Other Non Cash Items: 587000.00
PHAR balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 1099000.00
PHAR income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 507000.00
PHAR income_statement (annual, 2022-12-31) — Other Operating Expenses: 49662000.00
PHAR balance_sheet (annual, 2022-12-31) — Other Properties: 4691000.00
PHAR balance_sheet (annual, 2022-12-31) — Other Receivables: 1117000.00
PHAR balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 0.00
PHAR balance_sheet (annual, 2022-12-31) — Payables: 10852000.00
PHAR balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 54465000.00
PHAR balance_sheet (annual, 2022-12-31) — Prepaid Assets: 2288000.00
PHAR income_statement (annual, 2022-12-31) — Pretax Income: 14987000.00
PHAR cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 2281000.00
PHAR balance_sheet (annual, 2022-12-31) — Properties: 0.00
PHAR cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -601000.00
PHAR cash_flow (annual, 2022-12-31) — Purchase Of Investment: 0.00
PHAR balance_sheet (annual, 2022-12-31) — Raw Materials: 313000.00
PHAR balance_sheet (annual, 2022-12-31) — Receivables: 25331000.00
PHAR income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 11528000.00
PHAR income_statement (annual, 2022-12-31) — Reconciled Depreciation: 13188000.00
PHAR cash_flow (annual, 2022-12-31) — Repayment Of Debt: -3311000.00
PHAR income_statement (annual, 2022-12-31) — Research And Development: 52531000.00
PHAR balance_sheet (annual, 2022-12-31) — Restricted Cash: 213000.00
PHAR income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 0.00
PHAR balance_sheet (annual, 2022-12-31) — Retained Earnings: -256431000.00
PHAR income_statement (annual, 2022-12-31) — Salaries And Wages: 47726000.00
PHAR cash_flow (annual, 2022-12-31) — Sale Of Business: 7300000.00
PHAR cash_flow (annual, 2022-12-31) — Sale Of Investment: 0.00
PHAR income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 6410000.00
PHAR income_statement (annual, 2022-12-31) — Selling General And Administration: 68853000.00
PHAR balance_sheet (annual, 2022-12-31) — Share Issued: 656348225.00
PHAR income_statement (annual, 2022-12-31) — Special Income Charges: 7866000.00
PHAR cash_flow (annual, 2022-12-31) — Stock Based Compensation: 6392000.00
PHAR balance_sheet (annual, 2022-12-31) — Stockholders Equity: 204638000.00
PHAR balance_sheet (annual, 2022-12-31) — Tangible Book Value: 129517000.00
PHAR income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 970798.23
PHAR income_statement (annual, 2022-12-31) — Tax Provision: 1313000.00
PHAR income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.09
PHAR balance_sheet (annual, 2022-12-31) — Taxes Receivable: 3250000.00
PHAR cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -1235000.00
PHAR balance_sheet (annual, 2022-12-31) — Total Assets: 425797000.00
PHAR balance_sheet (annual, 2022-12-31) — Total Capitalization: 336256000.00
PHAR balance_sheet (annual, 2022-12-31) — Total Debt: 166694000.00
PHAR balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 204638000.00
PHAR income_statement (annual, 2022-12-31) — Total Expenses: 195762000.00
PHAR balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 221159000.00
PHAR balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 148297000.00
PHAR balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 161461000.00
PHAR income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 18233000.00
PHAR income_statement (annual, 2022-12-31) — Total Other Finance Cost: 105000.00
PHAR balance_sheet (annual, 2022-12-31) — Total Tax Payable: 2099000.00
PHAR income_statement (annual, 2022-12-31) — Total Unusual Items: 11081000.00
PHAR income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 11081000.00
PHAR balance_sheet (annual, 2022-12-31) — Work In Process: 29553000.00
PHAR balance_sheet (annual, 2022-12-31) — Working Capital: 217802000.00
PHAR income_statement (annual, 2023-12-31) — +Operating Expense: 242393000.00
PHAR income_statement (annual, 2023-12-31) — +Total Revenue: 245316000.00
PHAR balance_sheet (annual, 2023-12-31) — Accounts Payable: 16022000.00
PHAR balance_sheet (annual, 2023-12-31) — Accounts Receivable: 35408000.00
PHAR balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -26931000.00
PHAR balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 478431000.00
PHAR income_statement (annual, 2023-12-31) — Amortization: 5635000.00
PHAR income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 5635000.00
PHAR balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 2020000.00
PHAR income_statement (annual, 2023-12-31) — Basic Average Shares: 67460000.00
PHAR income_statement (annual, 2023-12-31) — Basic EPS: -0.15
PHAR cash_flow (annual, 2023-12-31) — Beginning Cash Position: 207342000.00
PHAR balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 30959000.00
PHAR cash_flow (annual, 2023-12-31) — Capital Expenditure: -1464000.00
PHAR cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -1437000.00
PHAR balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 33123000.00
PHAR balance_sheet (annual, 2023-12-31) — Capital Stock: 7669000.00
PHAR balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 61741000.00
PHAR balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 213424000.00
PHAR cash_flow (annual, 2023-12-31) — Cash Dividends Paid: 0.00
PHAR cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -1039000.00
PHAR cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -129388000.00
PHAR cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -17302000.00
PHAR cash_flow (annual, 2023-12-31) — Change In Inventory: -14434000.00
PHAR cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -216000.00
PHAR cash_flow (annual, 2023-12-31) — Change In Payable: 16228000.00
PHAR cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 16228000.00
PHAR cash_flow (annual, 2023-12-31) — Change In Receivables: -18539000.00
PHAR cash_flow (annual, 2023-12-31) — Change In Working Capital: -16961000.00
PHAR cash_flow (annual, 2023-12-31) — Changes In Cash: -147729000.00
PHAR balance_sheet (annual, 2023-12-31) — Common Stock: 7669000.00
PHAR balance_sheet (annual, 2023-12-31) — Common Stock Equity: 218781000.00
PHAR balance_sheet (annual, 2023-12-31) — Construction In Progress: 179000.00
PHAR income_statement (annual, 2023-12-31) — Cost Of Revenue: 25212000.00
PHAR balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 50272000.00
PHAR balance_sheet (annual, 2023-12-31) — Current Assets: 316342000.00
PHAR balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 3616000.00
PHAR balance_sheet (annual, 2023-12-31) — Current Debt: 1824000.00
PHAR balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 5440000.00
PHAR balance_sheet (annual, 2023-12-31) — Current Liabilities: 77968000.00
PHAR cash_flow (annual, 2023-12-31) — Depreciation: 15925000.00
PHAR cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 15925000.00
PHAR income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 9156000.00
PHAR cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 15925000.00
PHAR income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 9156000.00
PHAR income_statement (annual, 2023-12-31) — Depreciation Income Statement: 3521000.00
PHAR income_statement (annual, 2023-12-31) — Diluted Average Shares: 67460000.00
PHAR income_statement (annual, 2023-12-31) — Diluted EPS: -0.15
PHAR income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -10548000.00
PHAR income_statement (annual, 2023-12-31) — EBIT: -6048000.00
PHAR income_statement (annual, 2023-12-31) — EBITDA: 9877000.00
PHAR income_statement (annual, 2023-12-31) — Earnings From Equity Interest: -289000.00
PHAR cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 289000.00
PHAR cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 2128000.00
PHAR cash_flow (annual, 2023-12-31) — End Cash Position: 61741000.00
PHAR balance_sheet (annual, 2023-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 6093000.00
PHAR cash_flow (annual, 2023-12-31) — Financing Cash Flow: -1039000.00
PHAR balance_sheet (annual, 2023-12-31) — Finished Goods: 18349000.00
PHAR cash_flow (annual, 2023-12-31) — Free Cash Flow: -18766000.00
PHAR cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 930000.00
PHAR cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 0.00
PHAR cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 0.00
PHAR income_statement (annual, 2023-12-31) — Gain On Sale Of Business: 0.00
PHAR income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 21279000.00
PHAR income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -3901000.00
PHAR balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -2057000.00
PHAR income_statement (annual, 2023-12-31) — General And Administrative Expense: 80684000.00
PHAR balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 71267000.00
PHAR balance_sheet (annual, 2023-12-31) — Gross PPE: 60397000.00
PHAR income_statement (annual, 2023-12-31) — Gross Profit: 220104000.00
PHAR income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 4663000.00
PHAR income_statement (annual, 2023-12-31) — Interest Expense: 5964000.00
PHAR income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 5964000.00
PHAR income_statement (annual, 2023-12-31) — Interest Income: 3663000.00
PHAR income_statement (annual, 2023-12-31) — Interest Income Non Operating: 3663000.00
PHAR cash_flow (annual, 2023-12-31) — Interest Paid Cff: -5134000.00
PHAR cash_flow (annual, 2023-12-31) — Interest Received Cfo: 2883000.00
PHAR balance_sheet (annual, 2023-12-31) — Inventory: 56760000.00
PHAR balance_sheet (annual, 2023-12-31) — Invested Capital: 357203000.00
PHAR cash_flow (annual, 2023-12-31) — Investing Cash Flow: -129388000.00
PHAR balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 8113000.00
PHAR balance_sheet (annual, 2023-12-31) — Investments And Advances: 10398000.00
PHAR balance_sheet (annual, 2023-12-31) — Investmentsin Associatesat Cost: 2285000.00
PHAR cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
PHAR balance_sheet (annual, 2023-12-31) — Land And Improvements: 0.00
PHAR balance_sheet (annual, 2023-12-31) — Leases: 5546000.00
PHAR balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 29507000.00
PHAR balance_sheet (annual, 2023-12-31) — Long Term Debt: 136598000.00
PHAR balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 166105000.00
PHAR cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
PHAR cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -4038000.00
PHAR balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 2285000.00
PHAR balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 18582000.00
PHAR income_statement (annual, 2023-12-31) — Minority Interests: 0.00
PHAR cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
PHAR balance_sheet (annual, 2023-12-31) — Net Debt: 76681000.00
PHAR income_statement (annual, 2023-12-31) — Net Income: -10548000.00
PHAR income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -10548000.00
PHAR income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -10548000.00
PHAR income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -10548000.00
PHAR income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -10548000.00
PHAR cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -12012000.00
PHAR income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -10548000.00
PHAR cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -27000.00
PHAR income_statement (annual, 2023-12-31) — Net Interest Income: -2435000.00
PHAR cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -149203000.00
PHAR cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -4038000.00
PHAR cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -4038000.00
PHAR income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -2435000.00
PHAR cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 21279000.00
PHAR balance_sheet (annual, 2023-12-31) — Net PPE: 33466000.00
PHAR balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 147514000.00
PHAR balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 29761000.00
PHAR balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 29761000.00
PHAR balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 92000.00
PHAR income_statement (annual, 2023-12-31) — Normalized EBITDA: -2838000.00
PHAR income_statement (annual, 2023-12-31) — Normalized Income: -21713319.68
PHAR cash_flow (annual, 2023-12-31) — Operating Cash Flow: -17302000.00
PHAR cash_flow (annual, 2023-12-31) — Operating Gains Losses: -20990000.00
PHAR income_statement (annual, 2023-12-31) — Operating Income: -22289000.00
PHAR income_statement (annual, 2023-12-31) — Operating Revenue: 245316000.00
PHAR balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 671073243.00
PHAR balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 1824000.00
PHAR balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -2057000.00
PHAR income_statement (annual, 2023-12-31) — Other Gand A: 14990000.00
PHAR income_statement (annual, 2023-12-31) — Other Income Expense: 12712000.00
PHAR balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 71267000.00
PHAR cash_flow (annual, 2023-12-31) — Other Non Cash Items: 5257000.00
PHAR balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 1528000.00
PHAR income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 286000.00
PHAR income_statement (annual, 2023-12-31) — Other Operating Expenses: 76822000.00
PHAR balance_sheet (annual, 2023-12-31) — Other Properties: 5131000.00
PHAR balance_sheet (annual, 2023-12-31) — Other Receivables: 2145000.00
PHAR balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 151683000.00
PHAR balance_sheet (annual, 2023-12-31) — Payables: 22256000.00
PHAR balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 72528000.00
PHAR balance_sheet (annual, 2023-12-31) — Prepaid Assets: 3543000.00
PHAR income_statement (annual, 2023-12-31) — Pretax Income: -12012000.00
PHAR cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 8133000.00
PHAR balance_sheet (annual, 2023-12-31) — Properties: 0.00
PHAR cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
PHAR cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -27000.00
PHAR cash_flow (annual, 2023-12-31) — Purchase Of Investment: -382014000.00
PHAR balance_sheet (annual, 2023-12-31) — Raw Materials: 705000.00
PHAR balance_sheet (annual, 2023-12-31) — Receivables: 42615000.00
PHAR income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 18443000.00
PHAR income_statement (annual, 2023-12-31) — Reconciled Depreciation: 15925000.00
PHAR cash_flow (annual, 2023-12-31) — Repayment Of Debt: -4038000.00
PHAR income_statement (annual, 2023-12-31) — Research And Development: 68914000.00
PHAR balance_sheet (annual, 2023-12-31) — Restricted Cash: 0.00
PHAR balance_sheet (annual, 2023-12-31) — Retained Earnings: -265262000.00
PHAR income_statement (annual, 2023-12-31) — Salaries And Wages: 65694000.00
PHAR cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
PHAR cash_flow (annual, 2023-12-31) — Sale Of Investment: 232811000.00
PHAR income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 6817000.00
PHAR income_statement (annual, 2023-12-31) — Selling General And Administration: 87501000.00
PHAR balance_sheet (annual, 2023-12-31) — Share Issued: 671073243.00
PHAR income_statement (annual, 2023-12-31) — Special Income Charges: 16616000.00
PHAR cash_flow (annual, 2023-12-31) — Stock Based Compensation: 9251000.00
PHAR balance_sheet (annual, 2023-12-31) — Stockholders Equity: 218781000.00
PHAR balance_sheet (annual, 2023-12-31) — Tangible Book Value: 147514000.00
PHAR income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 1549680.32
PHAR income_statement (annual, 2023-12-31) — Tax Provision: -1464000.00
PHAR income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.12
PHAR balance_sheet (annual, 2023-12-31) — Taxes Receivable: 5062000.00
PHAR cash_flow (annual, 2023-12-31) — Taxes Refund Paid: -655000.00
PHAR balance_sheet (annual, 2023-12-31) — Total Assets: 462854000.00
PHAR balance_sheet (annual, 2023-12-31) — Total Capitalization: 355379000.00
PHAR balance_sheet (annual, 2023-12-31) — Total Debt: 171545000.00
PHAR balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 218781000.00
PHAR income_statement (annual, 2023-12-31) — Total Expenses: 267605000.00
PHAR balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 244073000.00
PHAR balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 146512000.00
PHAR balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 166105000.00
PHAR income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -5387000.00
PHAR income_statement (annual, 2023-12-31) — Total Other Finance Cost: 134000.00
PHAR balance_sheet (annual, 2023-12-31) — Total Tax Payable: 6234000.00
PHAR income_statement (annual, 2023-12-31) — Total Unusual Items: 12715000.00
PHAR income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 12715000.00
PHAR balance_sheet (annual, 2023-12-31) — Work In Process: 37706000.00
PHAR balance_sheet (annual, 2023-12-31) — Working Capital: 238374000.00
PHAR income_statement (quarterly, 2024-09-30) — Basic Average Shares: 51700000.00
PHAR income_statement (quarterly, 2024-09-30) — Basic EPS: -0.02
PHAR income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 51700000.00
PHAR income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.02
PHAR income_statement (quarterly, 2024-09-30) — Gain On Sale Of Security: 21000.00
PHAR balance_sheet (quarterly, 2024-09-30) — Net Debt: 34756000.00
PHAR income_statement (quarterly, 2024-09-30) — Other Operating Expenses: -777000.00
PHAR cash_flow (quarterly, 2024-09-30) — Sale Of Intangibles: 0.00
PHAR income_statement (quarterly, 2024-09-30) — Total Unusual Items: 21000.00
PHAR income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 21000.00
PHAR income_statement (annual, 2024-12-31) — +Operating Expense: 265466000.00
PHAR income_statement (annual, 2024-12-31) — +Total Revenue: 297200000.00
PHAR balance_sheet (annual, 2024-12-31) — Accounts Payable: 10103000.00
PHAR balance_sheet (annual, 2024-12-31) — Accounts Receivable: 41531000.00
PHAR balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -29949000.00
PHAR balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -29949000.00
PHAR balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 488990000.00
PHAR income_statement (annual, 2024-12-31) — Amortization: 6041000.00
PHAR income_statement (annual, 2024-12-31) — Amortization Of Intangibles Income Statement: 6041000.00
PHAR income_statement (annual, 2024-12-31) — Basic Average Shares: 68775000.00
PHAR income_statement (quarterly, 2024-12-31) — Basic Average Shares: 72500000.00
PHAR income_statement (annual, 2024-12-31) — Basic EPS: -0.16
PHAR income_statement (quarterly, 2024-12-31) — Basic EPS: 0.04
PHAR cash_flow (annual, 2024-12-31) — Beginning Cash Position: 61741000.00
PHAR balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 24534000.00
PHAR balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 24534000.00
PHAR cash_flow (annual, 2024-12-31) — Capital Expenditure: -796000.00
PHAR cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -790000.00
PHAR balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 29914000.00
PHAR balance_sheet (annual, 2024-12-31) — Capital Stock: 7769000.00
PHAR balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 54944000.00
PHAR balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 167893000.00
PHAR cash_flow (annual, 2024-12-31) — Cash Dividends Paid: 0.00
PHAR cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -34412000.00
PHAR cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 31618000.00
PHAR cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -1795000.00
PHAR cash_flow (annual, 2024-12-31) — Change In Inventory: -503000.00
PHAR cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -17000.00
PHAR cash_flow (annual, 2024-12-31) — Change In Payable: -2769000.00
PHAR cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -2769000.00
PHAR cash_flow (annual, 2024-12-31) — Change In Receivables: -6783000.00
PHAR cash_flow (annual, 2024-12-31) — Change In Working Capital: -10072000.00